1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLAND PHARMA LTD.
Gland Pharma Ltd.
NSE: GLAND | BSE: 543245
Strong Performer, Getting Expensive
In 1 Starfolio Basket
Download real time
US FDA Inspections ANDA Approvals
3052.30 -38.80 (-1.26%)
New 52W High in past week
423.7K
NSE+BSE Volume

NSE 14 Oct, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert


Board Meetings - Gland Pharma

The latest board meeting for Gland Pharma took place on 10 Aug 2026, for the purpose of Quarterly Results

Share
Ex-date Purpose Notes
10 Aug 2026 Quarterly Results -
15 May 2026 Audited Results & Final Dividend -
28 Jan 2026 Quarterly Results -
03 Nov 2025 Quarterly Results -
05 Aug 2025 Quarterly Results -
20 May 2025 Audited Results & Final Dividend -
03 Feb 2025 Quarterly Results -
04 Nov 2024 Quarterly Results -
06 Aug 2024 Quarterly Results -
22 May 2024 Audited Results & Final Dividend -
14 Feb 2024 Quarterly Results -
06 Nov 2023 Quarterly Results -
07 Aug 2023 Quarterly Results -
18 May 2023 Audited Results & A.G.M. -
23 Jan 2023 Quarterly Results -
26 Oct 2022 Quarterly Results -
20 Jul 2022 Quarterly Results -
19 May 2022 Audited Results -
21 Jan 2022 Quarterly Results -
22 Oct 2021 Quarterly Results -
21 Jul 2021 Quarterly Results -
17 May 2021 Audited Results -
22 Jan 2021 Quarterly Results -